Condition
Hemodynamic Management
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting4
Terminated1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07163858Not ApplicableRecruiting
Postural Mobilization Compared to Noradrenaline Only in Off-Pump CABG Surgery
NCT07062744Not ApplicableRecruiting
The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
NCT05149196Not ApplicableRecruiting
Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy
NCT06862700Recruiting
Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients
NCT03208023Not ApplicableTerminated
RESIPI for Reducing Perioperative Major Adverse Cardiac Events
Showing all 5 trials